A detailed history of Pnc Financial Services Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 4,598,989 shares of BMY stock, worth $245 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
4,598,989
Previous 4,748,876 3.16%
Holding current value
$245 Million
Previous $258 Million 25.84%
% of portfolio
0.13%
Previous 0.18%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$40.25 - $52.99 $6.03 Million - $7.94 Million
-149,887 Reduced 3.16%
4,598,989 $191 Million
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $1.51 Million - $1.71 Million
-31,449 Reduced 0.66%
4,748,876 $258 Million
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $9.29 Million - $11.1 Million
-191,569 Reduced 3.85%
4,780,325 $245 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $6.47 Million - $7.24 Million
-111,818 Reduced 2.2%
4,971,894 $289 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $3.65 Million - $4.06 Million
-57,333 Reduced 1.12%
5,083,712 $325 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $2.2 Million - $2.49 Million
-33,467 Reduced 0.65%
5,141,045 $356 Million
Q4 2022

Feb 10, 2023

SELL
$68.48 - $81.09 $1.99 Million - $2.36 Million
-29,126 Reduced 0.56%
5,174,512 $372 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $24,447 - $14.5 Million
-188,056 Reduced 3.49%
5,203,638 $370 Million
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $5.05 Million - $5.56 Million
-69,503 Reduced 1.27%
5,391,694 $415 Million
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $1.78 Million - $2.14 Million
-29,023 Reduced 0.53%
5,461,197 $399 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $7.63 Million - $8.9 Million
-142,307 Reduced 2.53%
5,490,220 $342 Million
Q3 2021

Nov 05, 2021

SELL
$59.17 - $69.31 $69.8 Million - $81.8 Million
-1,179,643 Reduced 17.32%
5,632,527 $333 Million
Q2 2021

Aug 06, 2021

SELL
$61.91 - $67.42 $8.37 Million - $9.12 Million
-135,275 Reduced 1.95%
6,812,170 $455 Million
Q1 2021

May 07, 2021

SELL
$59.34 - $66.74 $7.01 Million - $7.89 Million
-118,148 Reduced 1.67%
6,947,445 $439 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $5.84 Million - $6.62 Million
-101,218 Reduced 1.41%
7,065,593 $438 Million
Q3 2020

Nov 06, 2020

BUY
$57.43 - $63.64 $5.95 Million - $6.6 Million
103,674 Added 1.47%
7,166,811 $432 Million
Q2 2020

Aug 07, 2020

BUY
$54.82 - $64.09 $42.8 Million - $50.1 Million
781,271 Added 12.44%
7,063,137 $415 Million
Q1 2020

May 08, 2020

BUY
$46.4 - $67.43 $3.22 Million - $4.68 Million
69,345 Added 1.12%
6,281,866 $350 Million
Q4 2019

Feb 07, 2020

BUY
$49.21 - $64.19 $2.76 Million - $3.6 Million
56,097 Added 0.91%
6,212,521 $399 Million
Q3 2019

Nov 08, 2019

SELL
$42.77 - $50.71 $5.47 Million - $6.49 Million
-127,968 Reduced 2.04%
6,156,424 $312 Million
Q2 2019

Aug 09, 2019

SELL
$44.62 - $49.34 $26.7 Million - $29.5 Million
-597,928 Reduced 8.69%
6,284,392 $0
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $1.53 Million - $1.83 Million
33,927 Added 0.5%
6,882,320 $0
Q4 2018

Feb 08, 2019

BUY
$48.76 - $63.23 $17.4 Million - $22.5 Million
356,482 Added 5.49%
6,848,393 $356 Million
Q3 2018

Nov 09, 2018

BUY
$55.19 - $62.25 $48.2 Million - $54.3 Million
872,789 Added 15.53%
6,491,911 $0
Q2 2018

Aug 10, 2018

SELL
$50.53 - $62.98 $7.63 Million - $9.51 Million
-150,990 Reduced 2.62%
5,619,122 $0
Q1 2018

May 11, 2018

SELL
$59.92 - $68.98 $11.8 Million - $13.6 Million
-197,169 Reduced 3.3%
5,770,112 $0
Q4 2017

Feb 09, 2018

SELL
$59.94 - $65.35 $6.36 Million - $6.93 Million
-106,070 Reduced 1.75%
5,967,281 $0
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $335 Million - $387 Million
6,073,351
6,073,351 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.